Terms: = Lung cancer AND HERPUD1, ENSG00000051108, 9709, Q15011, SUP, Mif1, KIAA0025, HERP
28 results:
1. Identification of a m
Li D; Chen T; Li QG
BMC Pulm Med; 2023 Apr; 23(1):128. PubMed ID: 37072786
[TBL] [Abstract] [Full Text] [Related]
2. PDGF-β and IL-18 Expressions on Carcinoma Cervical by
Simanullang RH; Situmorang PC; Ginting L; Tarigan ER; Syahputra RA; Chairunisa C; Maliki MF
Pak J Biol Sci; 2022 Jan; 25(11):986-992. PubMed ID: 36591929
[TBL] [Abstract] [Full Text] [Related]
3. New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis,
Yaseen YS; Mahmood AAR; Abbas AH; Shihab WA; Tahtamouni LH
Med Chem; 2023; 19(5):445-459. PubMed ID: 36537605
[TBL] [Abstract] [Full Text] [Related]
4. Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules.
Zhang X; Yu Z; Xu Y; Chao Y; Hu Q; Li C; Ye M; Zhu X; Cui L; Bai J; Gong Y; Guan Y; Zhou M; Huang J; Zhang H; Ren T; Shen Q; Wang K; Hou Y; Xia X; Pu X; Carbone DP; Zhang X
Br J Cancer; 2022 Dec; 127(12):2154-2165. PubMed ID: 36253524
[TBL] [Abstract] [Full Text] [Related]
5. Reconstruction-Assisted Feature Encoding Network for Histologic Subtype Classification of Non-Small Cell lung cancer.
Li H; Song Q; Gui D; Wang M; Min X; Li A
IEEE J Biomed Health Inform; 2022 Sep; 26(9):4563-4574. PubMed ID: 35849680
[TBL] [Abstract] [Full Text] [Related]
6. Sarcoma of unknown primary: myth or reality?
Rassy E; Abou-Jaoude R; Boussios S; Assi T; Kattan J; Khaled H; Pavlidis N
J Egypt Natl Canc Inst; 2022 Jun; 34(1):27. PubMed ID: 35754068
[TBL] [Abstract] [Full Text] [Related]
7. The p97-Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis.
Re Cecconi AD; Barone M; Gaspari S; Tortarolo M; Bendotti C; Porcu L; Terribile G; Piccirillo R
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2225-2241. PubMed ID: 35611892
[TBL] [Abstract] [Full Text] [Related]
8. Design and application of tumor prediction model based on statistical method<sup/>.
Shen S; Fan Z; Guo Q
Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):232-239. PubMed ID: 29037067
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
Wang C; Zhang X; Li H; Li X; Lin Y
PLoS One; 2017; 12(7):e0179664. PubMed ID: 28704384
[TBL] [Abstract] [Full Text] [Related]
10. Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell lung cancer.
Chisaki Y; Nakamura N; Yano Y
Biol Pharm Bull; 2017; 40(1):73-81. PubMed ID: 28049952
[TBL] [Abstract] [Full Text] [Related]
11. Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma.
Ceccon M; Mologni L; Giudici G; Piazza R; Pirola A; Fontana D; Gambacorti-Passerini C
Mol Cancer Res; 2015 Apr; 13(4):775-83. PubMed ID: 25421750
[TBL] [Abstract] [Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Liu Z; Yue X; Song Z; Peng X; Guo J; Ji Y; Cheng Z; Ding J; Ai J; Geng M; Zhang A
Eur J Med Chem; 2014 Oct; 86():438-48. PubMed ID: 25200979
[TBL] [Abstract] [Full Text] [Related]
13. suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.
Bode C; Kinjo T; Alvord WG; Klinman DM
Carcinogenesis; 2014 May; 35(5):1078-83. PubMed ID: 24403310
[TBL] [Abstract] [Full Text] [Related]
14. suppressive oligodeoxynucleotides synergistically enhance antiproliferative effects of anticancer drugs in A549 human lung cancer cells.
Takahashi R; Sato T; Klinman DM; Shimosato T; Kaneko T; Ishigatsubo Y
Int J Oncol; 2013 Feb; 42(2):429-36. PubMed ID: 23291718
[TBL] [Abstract] [Full Text] [Related]
15. Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors.
Ceccon M; Mologni L; Bisson W; Scapozza L; Gambacorti-Passerini C
Mol Cancer Res; 2013 Feb; 11(2):122-32. PubMed ID: 23239810
[TBL] [Abstract] [Full Text] [Related]
16. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
Cheng M; Quail MR; Gingrich DE; Ott GR; Lu L; Wan W; Albom MS; Angeles TS; Aimone LD; Cristofani F; Machiorlatti R; Abele C; Ator MA; Dorsey BD; Inghirami G; Ruggeri BA
Mol Cancer Ther; 2012 Mar; 11(3):670-9. PubMed ID: 22203728
[TBL] [Abstract] [Full Text] [Related]
17. Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study.
Vergnenegre A; Corre R; Berard H; Paillotin D; Dujon C; Robinet G; Crequit J; Bota S; Thomas P; Chouaid C;
J Thorac Oncol; 2011 Jan; 6(1):161-8. PubMed ID: 21150465
[TBL] [Abstract] [Full Text] [Related]
18. Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.
Joo JH; Liao G; Collins JB; Grissom SF; Jetten AM
Cancer Res; 2007 Aug; 67(16):7929-36. PubMed ID: 17699800
[TBL] [Abstract] [Full Text] [Related]
19. Ectopic expression of DICE1 suppresses tumor cell growth.
Wieland I; Sell C; Weidle UH; Wieacker P
Oncol Rep; 2004 Aug; 12(2):207-11. PubMed ID: 15254679
[TBL] [Abstract] [Full Text] [Related]
20. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
[TBL] [Abstract] [Full Text] [Related]
[Next]
